BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 6293980)

  • 1. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
    Sturfelt G; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
    Jonsson H; Sturfelt G; Mårtensson U; Truedsson L; Sjöholm AG
    Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
    Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
    Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential studies of complement activation in systemic lupus erythematosus.
    Sturfelt G; Johnson U; Sjöholm AG
    Scand J Rheumatol; 1985; 14(2):184-96. PubMed ID: 4001891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes and C1 activation in patients with rapidly progressive glomerulonephritis, before and after treatment with immunosuppression and plasma exchange.
    Sjöholm AG; Brun C; Larsen S; Thysell H
    Int Arch Allergy Appl Immunol; 1983; 72(1):9-15. PubMed ID: 6874103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
    Waldo FB; West CD
    Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of age and sex on serum complement components in children.
    Roach B; Kim Y; Jerome E; Michael AF
    Am J Dis Child; 1981 Oct; 135(10):918-20. PubMed ID: 6975036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 activation and dissociation in disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
    Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
    J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
    Lockshin MD; Qamar T; Redecha P; Harpel PC
    Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.
    Radanova M; Vasilev V; Mihaylova G; Kosturkova M; Kishore U; Roumenina L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus.
    Nived O; Linder C; Odeberg H; Svensson B
    Ann Rheum Dis; 1985 Apr; 44(4):252-9. PubMed ID: 3872638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical hypocomplementemic vasculitis syndrome in a child.
    Waldo FB; Leist PA; Strife CF; Forristal J; West CD
    J Pediatr; 1985 May; 106(5):745-50. PubMed ID: 2987470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.